Roth Capital upped their FY2024 earnings per share estimates for shares of Creative Medical Technology in a report released on Wednesday, November 13th. Roth Capital analyst J. Aschoff now expects ...
When conversations about cancer arise, common narratives often centre on breast, lung, or colon cancer. While these deserve their spotlight, prostate cancer ...